Nike Inc. is asking the International Trade Commission in Washington to block imports of Adidas AG Primeknit shoes for infringing its patented invention for a knitted fabric that reduces waste while maintaining performance.
The patents are for Nike’s FlyKnit technology, which creates a sock-like fit in the upper part of the shoe by using the use of specialized yarn from recycled and reclaimed materials.
Nike said it developed the technology by spending over $100 million for a decade of research and it was the first major technological innovation in footwear uppers in decades.
The shoes that Nike hopes to ban include Adidas by Stella McCartney Ultraboost, Pharrell Williams Superstar Primeknit Shoes, and Terrex Free Hiker hiking shoes.
Nike also made similar allegations in its patent-infringement suit in federal court in Oregon.
After FlyKnit was introduced before the 2012 London Olympics, it has been adopted by hoops icon LeBron James, soccer superstar Cristiano Ronaldo, and world record marathoner Eliud Kipchoge.
Nike said that Adidas has forgone independent innovation while spending the past decade unsuccessfully challenging several of its FlyKnit technology patents while using Nike’s patented technology without permission.
According to Nike, it was forced to sue Adidas for its unauthorized use to defend its investments.
Meanwhile, Adidas said it would defend itself against the allegations..
Adidas spokeswoman Mandy Nieber claims that its Primeknit technology resulted from years of dedicated research.


Appeals Court Rejects Trump Bid to Reinstate $100,000 H-1B Visa Fee
Bashar al-Assad Sentenced to Death by Syrian Court
European Stocks Slide as Iran War Escalation Sends Oil Higher
Peru Court Frees Former President Ollanta Humala After Conviction Overturned
Morgan Stanley Sees Fed Holding Rates as U.S. Inflation Cools
Micron Stock Upgraded to Buy as New Street Sees $2 Trillion Valuation Potential
Paramount-Warner Bros. Merger Delayed Until 2027 Amid Antitrust Lawsuit
Nvidia Eyes $3 Billion Investment in SoftBank-Backed AI Data Center
Australian Consumer Sentiment Jumps 6% in August as Rate Outlook Improves
Alphabet Eyes First Australian Dollar Bond as AI Spending Drives Funding Push
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits
European Stocks Edge Higher as Fed Rate Pause Bets Rise
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Alphabet Shifts AI Strategy Toward Commercial Growth, Goldman Sachs Says
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico
Maduro U.S. Drug Trafficking Trial Set for June 2027 as Immunity Defense Looms 



